Biopharmaceutical company Hansa Medical AB, has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in glycobiology.
Hansa Medical AB expects that the transaction will provide it with rights to cancer immunotherapy using antibody-modulating enzymes.
Qingdao Gon Technology has announced its plans to acquire an undisclosed pharmaceutical company.
The company expects the acquisition to cost them up to $26.59m.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Clinical Trials Arena Excellence Awards - Have you nominated?
Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!
Nominate Now
